Fundz

Senda Biosciences Announces Closing Of $98 Million Series B Financing

PRIVATEJun 10, 2021

Amount Raised

$98 Million

Round Type

Series B

CambridgeVenture Capital

Description

Senda Biosciences, a company that is systematically harnessing the powerful molecular interactions that have evolved over millennia between humans, plants, and bacteria to develop new types of medicines, announced today the completion of a $55 million Series B extension financing, bringing its total Series B funding to $98 million and total funding raised to date to $143 million. Proceeds from the financing will be used to advance the development of Senda's platform and its therapeutic programs into clinical trials. Flagship Pioneering, Senda's founder, participated along with new investors including Longevity Vision Fund, Terra Magnum Capital Partners, Mayo Clinic, Partners Investment and Mint Venture Partners. Current investors Alexandria Venture Investments and State of Michigan Retirement System also participated.

Quick answer

Senda Biosciences raised $98 Million in a Series B round, dated June 10, 2021. Senda Biosciences is based in Cambridge, Maryland, United States.

How much did Senda Biosciences raise?
Senda Biosciences raised $98 Million in a Series B round on June 10, 2021.
What does Senda Biosciences do?
Senda Biosciences, Inc. is committed to bringing life-changing treatments to patients by harnessing millennia of evolution to program human cells both within and to the cell.
Where is Senda Biosciences based and how big is it?
Senda Biosciences is based in Cambridge, Maryland, United States.
Who are the decision-makers at Senda Biosciences?
Fundz holds 1 contact at Senda Biosciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Venture Capital around the same time

Companies in the same sectors as Senda Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Anterra Capital raised an undisclosed amount (Funding Round) on June 29, 2021.
  • NotCo raised $10M on June 8, 2021.
  • NotCo raised an undisclosed amount (Private Equity) on June 2, 2021.
  • Energy Exploration Technologies raised $7.7M on May 25, 2021.
  • Energy Exploration Technologies raised $20M (Funding Round) on May 7, 2021.
  • Veritas Capital raised an undisclosed amount (Funding Round) on May 5, 2021.

Who to call at Senda Biosciences, and when

A new round usually means Senda Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Senda Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Senda Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Senda Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Senda Biosciences

Location

Cambridge, Maryland, United States

About

Senda Biosciences, Inc. is committed to bringing life-changing treatments to patients by harnessing millennia of evolution to program human cells both within and to the cell. Senda’s proprietary platform is the first to leverage a universal chemical routing code of natural nanoparticles that enable cross- kingdom intercellular communication. This platform unlocks comprehensive programming of medicines for the first time, allowing Senda to develop a new class of SendRNATM medicines focused initially on powering new frontiers in immunology mRNA-based therapies, with future applications employing other information molecules, including siRNA, gene editors, proteins, and peptides. Headquartered in Cambridge, Massachusetts, Senda was founded by Flagship Pioneering. For more information, visit www.sendabiosciences.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Senda Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Senda Biosciences's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Senda Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.